Strategas Macro Thematic Opportunities ETF
SAMT
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 52 Vanderbilt Avenue New York City DE United States of America 10017
- IPO Date
- Jan 25, 2022
- CIK
- 0001593547
- Website
- strategasetfs.com
- Similar Companies
- Business
- Strategas Macro Thematic Opportunities ETF (SAMT) is an actively managed exchange-traded fund that leverages macro research to identify and allocate to three to five high-conviction, durable intermediate-term investment themes, seeking to outperform the broader market through exposure to U.S.-listed stocks across market capitalizations that meet liquidity parameters; current themes as of mid-2025 include Artificial Intelligence, Cash Flow Aristocrats, De-Globalization, and Industrial Power Renaissance, with top sector exposures in industrials, financials, information technology, utilities, and communication services; the fund adjusts thematic positioning dynamically based on shifts in macro trends to maintain thesis integrity. SAMT, with a total expense ratio of 0.66%, trades on NYSE Arca under ticker SAMT (CUSIP 00775Y645), benchmarked against the S&P 500, and features an active share of 86% with 37 holdings as of June 2025; assets under management reached approximately $335 million as of December 2025, with a NAV of $38.40 and market price of $38.41; the fund was incepted on January 24, 2022, and is managed by Strategas Asset Management, LLC (investment advisor), with Vident Investment Advisory, LLC as sub-advisor and SEI Investments Distribution Co. as distributor. Headquartered at 52 Vanderbilt Avenue, 19th Floor, New York, New York 10017, the fund targets institutional and retail investors seeking thematic equity exposure amid evolving macro environments; notable holdings as of late 2025 include cash (12.70%), Planet Labs PBC (PL), Rocket Lab Corp (RKLB), Cencora Inc (COR), and Merck & Co. Inc. (MRK). In recent developments, SAMT demonstrated strong performance driven by its deglobalization theme during the third quarter of 2025, amid ongoing AI dominance and shifts in global trade dynamics; the fund surpassed key asset milestones, including $60 million in 2022 and growth to over $300 million by late 2025, reflecting increased investor interest in its unconstrained, hedge-fund-like flexibility and high turnover strategy; portfolio managers continue to rotate themes based on macro research, with no major acquisitions, partnerships, or structural changes reported in the last 1-2 years.